Deadline: August 10, 2018
The goal of this pilot grant program is to develop innovative assays that can be deployed in our CRISPR platform to identify novel regulators of immune responses to acute infection and/or to develop computational approaches for analyzing single cell data. These grants will provide support for generating preliminary data for future applications for independent research support.
Goals:
- Stimulate innovation in two main areas:
New and innovative assays that could be deployed in an in vivo or in vitro CRISPR screening platform to understand innate and adaptive immune responses triggered by pathogens, adjuvants, or vaccines. These might include new methodologies or cell phenotypes for screens.
The development of new tools, reagents, and computational methods to generate better single cell data and to analyze the data arising from the U19 projects.
- Support research initiated by early career investigators
ELIGIBLITY
Any faculty member who holds an appointment at Harvard University as an assistant professor, associate professor, or professor, irrespective of type of degree or institutional affiliation, is eligible to be the PI. Faculty members at MIT who hold appointments as assistant professors, associate professors, or professors are also eligible. Please see the RFA and FAQs for more information.
Applicants may submit proposals with requests for up to $75,000.
QUESTIONS?
If you have questions, please contact us.
Please see the website for complete information.